ÂÜÀòÂÒÂ×

Adam Laponis serves as Chief Financial Officer at Twist Bioscience since January 2024. Prior to this role, Laponis held the CFO position at Eargo from 2019 to 2024 and was VP Finance at Tesla from 2017 to 2019, overseeing worldwide financial planning and analysis. Additional experience includes serving as VP Finance and CFO for Cardiovascular Care at Cardinal Health (2015-2017) and various senior finance roles at Johnson & Johnson from 2004 to 2015. Laponis's earlier career includes positions at Rosecreek Capital, BenefitPoint, Inc., and SRI International, where expertise in finance and engineering was developed. Laponis holds an MBA in Finance, Strategy, and Operations from USC Marshall School of Business and a BS in Chemical Engineering from the University of California, Berkeley.